Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exagen (XGN) Other Non Operating Income (2018 - 2023)

Historic Other Non Operating Income for Exagen (XGN) over the last 7 years, with Q2 2025 value amounting to -$295000.0.

  • Exagen's Other Non Operating Income changed N/A to -$295000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was -$295000.0, marking a year-over-year decrease of 14294.03%. This contributed to the annual value of $16000.0 for FY2021, which is 9837.4% down from last year.
  • Per Exagen's latest filing, its Other Non Operating Income stood at -$295000.0 for Q2 2025.
  • Over the past 5 years, Exagen's Other Non Operating Income peaked at $476000.0 during Q2 2023, and registered a low of -$295000.0 during Q2 2025.
  • For the 4-year period, Exagen's Other Non Operating Income averaged around $75700.0, with its median value being $5000.0 (2022).
  • In the last 5 years, Exagen's Other Non Operating Income tumbled by 10072.57% in 2021 and then skyrocketed by 1120000.0% in 2022.
  • Quarter analysis of 4 years shows Exagen's Other Non Operating Income stood at $15000.0 in 2021, then skyrocketed by 2160.0% to $339000.0 in 2022, then crashed by 37.76% to $211000.0 in 2023, then plummeted by 239.81% to -$295000.0 in 2025.
  • Its Other Non Operating Income was -$295000.0 in Q2 2025, compared to $211000.0 in Q3 2023 and $476000.0 in Q2 2023.